Therasense : Raising the Bar for Inequitable Conduct - Finnegan
Addressing the standards necessary to prove inequitable conduct in patent cases, the U.S. Court of Appeals for the Federal Circuit, sitting en banc, recently added new contours to a doctrine that, in its words, “has plagued not only the courts but also the entire patent system.”.
Clarity: A First Look at Therasense, Inc. v. Becton ... - Finnegan
With the Therasense decision, the U.S. Court of Appeals for the Federal Circuit has created a new, tightened standard for alleging inequitable conduct. Therasense has clarified the expectations for attorneys and applicants and provided them with more effective tools to address difficult situations.
The TheraSense Continuous Glucose Monitor helps people with diabetes monitor their sugar (glucose) level. The system provides glucose values on a continual basis allowing you to see patterns in your
Abbott to Acquire TheraSense for $1.2 Billion - HomeCare …
2004年2月1日 · Abbott Laboratories will acquire diabetes test-maker TheraSense Inc., which manufactures FreeStyle blood glucose self-monitoring systems, for $1.2 billion. TheraSense, Alameda, Calif., entered the market in mid-2000 and has specialized in products requiring very small blood sample sizes.
Assessing Materiality and Intent in a Post- Therasense World
2013年2月15日 · Indeed, Therasense has ushered in an era of tightened scrutiny for the doctrine, making it easier to defend against spurious allegations of inequitable conduct. The Federal Circuit's post-Therasense decisions emphasize the importance of both the invalidity analysis and the assessment of witness credibility to the doctrine of inequitable conduct ...
Therasense v. Becton, Dickinson and Co. - Case Brief Summary for …
Facts. The case revolves around U.S. Patent No. 5,820,551 ("the '551 patent"), owned by Therasense, Inc. (now Abbott Diabetes Care, Inc.) and Abbott Laboratories (collectively, "Abbott"), which describes disposable blood glucose test strips used in diabetes management.
INSIGHT: Inequitable Conduct Accusations Still Powerful Pharma …
2019年7月17日 · When proven, accusations of fraud-like behavior in the Patent Office make patents unenforceable, but the Federal Circuit has called such accusations a “plague” on the system. Cooley’s Jason A. Lief takes a look at the law of inequitable conduct after the Federal Circuit’s Therasense opinion.
The Increased Need for Experts in the Wake of the Federal Circuit
2011年8月22日 · In the much-anticipated Therasense Inc. v. Becton, Dickinson and Co. decision, a divided U.S. Court of Appeals for the Federal Circuit, sitting en banc, made fundamental changes to the law of inequitable conduct.
Article: Inequitable Conduct After Therasense: Calling a Knave …
The Therasense court was largely successful in its goal of eradicating the plague of weak and perfunctory inequitable conduct counterclaims, and with the Supreme Court’s recent decision not to review the heightened standard, Therasense is here to stay for the foreseeable future.
Alternate Site Glucose Monitoring: A Welcome Respite
2001年10月1日 · An insulin pump user, C.K. tests his blood glucose levels at least four times a day, 7 days a week. His careful monitoring of diet, exercise, and insulin has helped him keep his glycemia under control despite his hectic college schedule. The educator demonstrated the new Freestyle (Therasense) alternate site meter.